These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21528623)

  • 21. Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients.
    Nissle K; Kopf D; Rösler A
    BMC Geriatr; 2016 Nov; 16(1):185. PubMed ID: 27846818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-day prevalence of asymptomatic carriage of toxigenic and non-toxigenic Clostridioides difficile in 10 French hospitals.
    Le Monnier A; Candela T; Mizrahi A; Bille E; Bourgeois-Nicolaos N; Cattoir V; Farfour E; Grall I; Lecointe D; Limelette A; Marcade G; Poilane I; Poupy P; Kansau I; Zahar JR; Pilmis B;
    J Hosp Infect; 2022 Nov; 129():65-74. PubMed ID: 35640734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrointestinal colonization with a cephalosporinase-producing bacteroides species preserves colonization resistance against vancomycin-resistant enterococcus and Clostridium difficile in cephalosporin-treated mice.
    Stiefel U; Nerandzic MM; Pultz MJ; Donskey CJ
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4535-42. PubMed ID: 24867962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colonization and infection with multiple nosocomial pathogens among patients colonized with vancomycin-resistant Enterococcus.
    Donskey CJ; Ray AJ; Hoyen CK; Fuldauer PD; Aron DC; Salvator A; Bonomo RA
    Infect Control Hosp Epidemiol; 2003 Apr; 24(4):242-5. PubMed ID: 12725351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vancomycin-resistant
    Goić-Barišić I; Radić M; Novak A; Rubić Ž; Boban N; Lukšić B; Tonkić M
    Acta Clin Croat; 2020 Sep; 59(3):523-528. PubMed ID: 34177063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection?
    Gerding DN
    Clin Infect Dis; 1997 Sep; 25 Suppl 2():S206-10. PubMed ID: 9310680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Environmental shedding of toxigenic Clostridioides difficile by asymptomatic carriers: A prospective observational study.
    Gilboa M; Houri-Levi E; Cohen C; Tal I; Rubin C; Feld-Simon O; Brom A; Eden-Friedman Y; Segal S; Rahav G; Regev-Yochay G;
    Clin Microbiol Infect; 2020 Aug; 26(8):1052-1057. PubMed ID: 31904567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence of Clostridioides difficile and multidrug-resistant healthcare-associated pathogens in stool specimens from hospitalized patients in the USA.
    Tickler IA; Dela Cruz CM; Obradovich AE; Goering RV; Dewell S; Le VM; Tenover FC;
    J Hosp Infect; 2020 Sep; 106(1):179-185. PubMed ID: 32649974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fidaxomicin versus conventional antimicrobial therapy in 59 recipients of solid organ and hematopoietic stem cell transplantation with Clostridium difficile-associated diarrhea.
    Clutter DS; Dubrovskaya Y; Merl MY; Teperman L; Press R; Safdar A
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4501-5. PubMed ID: 23836168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic Determination of Relative Risks for Clostridioides difficile Infection From Asymptomatic Carriage in Intensive Care Unit Patients.
    Worley J; Delaney ML; Cummins CK; DuBois A; Klompas M; Bry L
    Clin Infect Dis; 2021 Oct; 73(7):e1727-e1736. PubMed ID: 32676661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of an automated ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens in hospital rooms.
    Nerandzic MM; Cadnum JL; Pultz MJ; Donskey CJ
    BMC Infect Dis; 2010 Jul; 10():197. PubMed ID: 20615229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection.
    Henning KJ; Delencastre H; Eagan J; Boone N; Brown A; Chung M; Wollner N; Armstrong D
    Pediatr Infect Dis J; 1996 Oct; 15(10):848-54. PubMed ID: 8895914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clostridium difficile rates in asymptomatic and symptomatic hospitalized patients using nucleic acid testing.
    Truong C; Schroeder LF; Gaur R; Anikst VE; Komo I; Watters C; McCalley E; Kulik C; Pickham D; Lee NJ; Banaei N
    Diagn Microbiol Infect Dis; 2017 Apr; 87(4):365-370. PubMed ID: 28087170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Room contamination, patient colonization pressure, and the risk of vancomycin-resistant Enterococcus colonization on a unit dedicated to the treatment of hematologic malignancies and hematopoietic stem cell transplantation.
    Ford CD; Lopansri BK; Gazdik MA; Webb B; Snow GL; Hoda D; Adams B; Petersen FB
    Am J Infect Control; 2016 Oct; 44(10):1110-1115. PubMed ID: 27287734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asymptomatic Carriers Contribute to Nosocomial Clostridium difficile Infection: A Cohort Study of 4508 Patients.
    Blixt T; Gradel KO; Homann C; Seidelin JB; Schønning K; Lester A; Houlind J; Stangerup M; Gottlieb M; Knudsen JD
    Gastroenterology; 2017 Apr; 152(5):1031-1041.e2. PubMed ID: 28063955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implications for vancomycin-resistant Enterococcus colonization associated with Clostridium difficile infections.
    Fujitani S; George WL; Morgan MA; Nichols S; Murthy AR
    Am J Infect Control; 2011 Apr; 39(3):188-93. PubMed ID: 21458682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital.
    Sohn KM; Peck KR; Joo EJ; Ha YE; Kang CI; Chung DR; Lee NY; Song JH
    Int J Infect Dis; 2013 Apr; 17(4):e240-6. PubMed ID: 23195640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial.
    Johnson S; Homann SR; Bettin KM; Quick JN; Clabots CR; Peterson LR; Gerding DN
    Ann Intern Med; 1992 Aug; 117(4):297-302. PubMed ID: 1322075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asymptomatic carriage of Clostridium difficile in an Irish continuing care institution for the elderly: prevalence and characteristics.
    Ryan J; Murphy C; Twomey C; Paul Ross R; Rea MC; MacSharry J; Sheil B; Shanahan F
    Ir J Med Sci; 2010 Jun; 179(2):245-50. PubMed ID: 19495833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients.
    Guerrero DM; Becker JC; Eckstein EC; Kundrapu S; Deshpande A; Sethi AK; Donskey CJ
    J Hosp Infect; 2013 Oct; 85(2):155-8. PubMed ID: 23954113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.